USHA Resources

About

Usha Resources Ltd. is a North American mineral acquisition and exploration company focused on the development of quality battery metal properties that are drill-ready with high-upside and expansion potential. Based in Vancouver, BC, Usha’s portfolio of strategic properties provides target-rich diversification and consist of Jackpot Lake, a lithium project in Nevada; White Willow, a lithium project in Ontario. Usha trades on the TSX Venture Exchange under the symbol USHA, the OTCQB Exchange under the symbol USHAF and the Frankfurt Stock Exchange under the symbol JO0.

All Content

Aerial Tesla in EV Carpark _ Wall Street Endeavor

Tesla FSD: Powering Up the Future of Driving

Tesla's Full Self-Driving (FSD) capability is rapidly evolving, offering a glimpse into a future where human intervention in driving becomes increasingly minimal....

Michigan Community Faces Divide Over Chinese-Backed EV Battery Plant

In Green Township, Michigan, a new EV battery factory offers significant economic potential, but its Chinese ties are causing local tension....
Hand holds a collection of Fluorspar rocks

Fluorspar: A Key Player Emerging in the Lithium-Ion Battery Boom

While everyone's talking about cobalt, nickel, and lithium, another critical mineral is quietly gaining importance in the lithium-ion battery revolution: fluorspar....
Pharma Analysis Doctor and Patient

Cancer treatment could identify patients most likely to respond to cancer drugs

Scientists from the Cancer Research UK Scotland Institute and Memorial Sloan Kettering Cancer Centre have discovered a cancer treatment that can identify patients who are more likely to respond to...

Record amount of medicinal cannabis in 2023

Germany Imports Record Quantity of Medicinal Cannabis in 2023...

Rio Tinto & BHP Collaboration looks to future of EV Haul Trucks

This is a significant development in the mining industry's efforts to reduce greenhouse gas emissions....
Pharmaceutical Research and Development in a Lab

NRx Pharmaceuticals’ Annual Meeting and Spinoff Plans

NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, plans to hold its 2023 Annual Meeting of Stockholders on December 19, 2023, in a virtual format. Key items on the agenda include the...

Innate Pharma Herve Brailly

Innate Pharma Leadership Change

Innate Pharma, a global clinical-stage biotechnology company, announced a major leadership transition. Mondher Mahjoubi, the Chief Executive Officer (CEO), has resigned to pursue an opportunity at a large pharmaceutical company....

Toronto Stock Exchange

OTC Markets

Frankfurt Stock Exchange

de_DEGerman